Waar? Malaga (Spain)
Wanneer? 09.11.2023 tot 11.11.2023
It is with great pleasure that we invite you to attend the 9th Trends in Head & Neck Oncology (THNO-9) meeting, which will be held face-to-face in Málaga, Spain, on November 9 – 11, 2023.
With a wealth of exciting new data emerging both from the laboratory and the clinic in this rapidly evolving field, THNO-9 will highlight innovations in the three traditional pillars of treatment, i.e., surgery, radiation, and chemotherapy, and will give relevant updates on the fourth pillar: immunotherapy. Multidisciplinary decision making during multidisciplinary team meetings is key in daily practice, taking into account practical guidelines that are being updated regularly. We will discuss active research in a number of emerging areas such as: potentially malignant disorders of the oral region, the role of artificial intelligence, innovations in cell-based assays for drug discovery and drug evaluation, the role of genomics and beyond in precision medicine, mechanism of action and potential use of SMAC mimetics, and the potential roles of antibody-drug conjugates in head & neck cancer. We will also address innovations in treatment and management including: intratumoral drug administration and metronomic chemotherapy with or without low dose immune checkpoint inhibitors, optimal local treatment in patients with metastatic head & neck cancer, sentinel node biopsy in cN0 early stage oral cavity cancer, partial laryngectomy, improving quality of reconstructive surgery, innovations in radiotherapy, such as proton therapy, FLASH therapy, and several ways to overcome hypoxia-induced (radio)resistance. Finally, in a separate session, the molecular characterization and its impact on treatment of salivary gland cancers and strategies how to improve outcome in salivary duct carcinoma will be highlighted. All disciplines involved in the treatment of head & neck cancer will be represented in integrated sessions. The translation to daily practice will be brought to the spotlight by interactive clinical case discussions facilitated by panels. The THNO-9 meeting is designed for all medical oncologists, surgeons, radiation oncologists, otolaryngologists, and other medical professionals involved in the treatment of patients with head & neck cancer. The THNO-9 face-to-face meeting will offer you excellent science and medicine in the beautiful city of Málaga. We look forward to welcoming you in Málaga!
Meeting chairs & scientific committee
Jan B. Vermorken, Edegem, Belgium
Hans Langendijk, Groningen, The Netherlands
René Leemans, Amsterdam, The Netherlands
Jean-Pascal Machiels, Brussels, Belgium
Piero Nicolai, Brescia, Italy
Brian O’Sullivan, Toronto, Canada
